ClinConnect ClinConnect Logo
Search / Trial NCT06634446

Self-administered COgnitive Personalized Training in Early Psychosis

Launched by CENTRE HOSPITALIER ST ANNE · Oct 8, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

First Episode Psychosis (Fep), Schizophrenia Cognitive Personalized Training Adolescents And Young Adults Fep Personalized Cognitive Training Chronic Psychosis Biological Testing Metabolic Alterations

ClinConnect Summary

This clinical trial, called SCOPe, is studying a new way to help young people who are experiencing their first episode of psychosis. The goal is to use a special online tool that allows participants to engage in personalized cognitive training, which focuses on improving thinking skills that may have been affected by psychosis. By starting this training early, researchers hope to enhance the quality of life and help with education and job opportunities for these young individuals. This approach is designed to be easy to access and use, so anyone can benefit from it, regardless of where they live.

To be eligible for the trial, participants need to be between 16 and 35 years old and recently diagnosed with psychosis. They must also be seeking help at one of the participating centers and able to provide written consent, with a guardian's consent if they are minors. Those interested can expect to use a user-friendly app to work on cognitive exercises tailored to their needs. It's important to note that individuals with severe health issues, significant reading difficulties, or those currently involved in other clinical trials will not be able to participate. Through this trial, researchers aim to understand how cognitive training can help young people recover better and improve their brain's ability to adapt and grow.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adolescent and young adults, both genders, aged 16 to 35,
  • Seeking help in one of the recruiting centers,
  • Newly diagnosed as experiencing an Episode of Psychosis (reaching criteria as described in the Comprehensive Assessment of at Risk Mental States (CAARMS) within the year
  • Written informed consent signed (and from one legal guardian for minors).
  • Exclusion Criteria:
  • Severe and unstabilized medical conditions,
  • Insufficient level in reading and/or French language,
  • Absence of medical insurance,
  • Participation in another intervention trial,
  • Enforced hospitalization (ASPDT, ASPPI, ASPRE),
  • Intellectuel Deficiency (IQ\<70), and / or sensorimotor deficits incompatible with the cognitive training,

About Centre Hospitalier St Anne

Centre Hospitalier St. Anne is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a strong emphasis on mental health and neurology, the center is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. By fostering collaboration among multidisciplinary teams of experienced researchers and healthcare professionals, Centre Hospitalier St. Anne aims to contribute to the development of new therapies and treatment modalities, ultimately enhancing the quality of care for patients in both local and global contexts.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Marie Odile MO KREBS, PROFESSEUR

Principal Investigator

GHU PARIS Saint-Anne

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported